VANCOUVER, BC, Jan. 21, 2025 /PRNewswire/ – Human in Motion Robotics, a global leader in robotic mobility and humanoid technology, is proud to announce that XoMotion™, the world’s most advanced medical exoskeleton, was named the Top Robot at CES 2025 by USA Today .
CES 2025, held January 7–10 in Las Vegas, brought together the brightest minds in technology, showcasing cutting-edge innovations across the globe. XoMotion received widespread recognition from attendees, media, and industry leaders for its transformative potential to assist individuals with mobility impairments caused by spinal cord injuries, strokes, and other neurological conditions.
Other Highlights from CES 2025
As CES 2025 concluded, Human in Motion Robotics celebrated a successful and well-received exhibition, highlighted by:
The event marked another milestone for Human in Motion Robotics, as the recognition and connections made during CES will drive future advancements and growth.
Meet Chloë Angus, Product Ambassador
A key highlight of the CES 2025 exhibition was the opportunity for attendees to meet Chloë Angus, Product Ambassador & Director of Lived Experience at Human in Motion Robotics. Chloë’s inspiring journey of overcoming adversity serves as a testament to the power of XoMotion. After a life-altering medical event, Chloë partnered with HMR to help develop XoMotion, leveraging her lived experience to ensure the exoskeleton truly addresses the needs of users.
**To schedule an interview with Chloe or request a full press kit from HMR, please contact:
** Phil Astrachan, VP of Marketing phil@humaninmotion.com 415-310-7466
A Groundbreaking Leap in Rehabilitation Technology
XoMotion’s innovative design and functionality redefine assistive technology. The exoskeleton provides hands-free, self-balancing support that mimics natural human movement, making it intuitive for patients to use while reducing the physical and cognitive strain on therapists.
Key Features of XoMotion:
Availability and Regulatory Advancement
Human in Motion Robotics is committed to making XoMotion accessible to those who need it most. XoMotion is currently available for acquisition by rehabilitation facilities in Canada. Additionally, XoMotion is available to scientific investigators conducting rehabilitation or robotics research worldwide.The device is undergoing clinical trials for FDA approval in the United States, with plans to expand its reach to other global markets, including Europe and Asia.
For more information or to request a demonstration, please visit humaninmotion.com or contact us at info@humaninmotion.com .
About Human in Motion Robotics
Based in Vancouver, Canada, Human in Motion Robotics is a leading innovator in robotic mobility and humanoid technology, dedicated to developing advanced solutions that improve patient outcomes and support healthcare professionals. Our mission is to transform the landscape of rehabilitation and personal mobility through cutting-edge technology and customer-centric design.
SOURCE Human in Motion Robotics Inc.
New HIPAA-compliant AI technology integrated into Tebra’s EHR platform reduces documentation time by up to…
This collaboration sets out to explore whether using the Matter Neuroscience protocol combined with real-time neurofeedback…
LINKÖPING, Sweden, June 3, 2025 /PRNewswire/ -- SyntheticMR AB (publ) is proud to share the…
Highly experienced biopharma executive Dr Cristina Csimma joins Asgard's Board of Directors, while esteemed immunologists…
Top 25 Global Life Science Organization Adopts NavaX, Demonstrating Industry Confidence in Scalable, GenAI-Enabled Technologies…
LONDON and MENLO PARK, Calif., June 3, 2025 /PRNewswire/ -- CareLineLive, an all-in-one home care…